Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients - van Vollenhoven, R F; Emery, P; Bingham, C O, 3rd; Keystone, E C; Fleischmann, R M; Furst, D E; Tyson, N; Collinson, N; Lehane, P B (Ann Rheum Dis, 2013)